BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30980126)

  • 21. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Xu C; Sun H; Du S; Xin J
    Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.
    Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
    Eur Radiol; 2018 Jan; 28(1):437-445. PubMed ID: 28779395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.
    Kozumi M; Ota H; Yamamoto T; Umezawa R; Matsushita H; Ishikawa Y; Takahashi N; Matsuura T; Takase K; Jingu K
    Eur Radiol; 2018 Oct; 28(10):4296-4305. PubMed ID: 29725833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
    Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
    Binbin T; Lingying W; Manni H; Jusheng A; Ning L
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor growth patterns on magnetic resonance imaging and treatment outcomes in patients with locally advanced cervical cancer treated with definitive radiotherapy.
    Tsuruoka S; Kataoka M; Hamamoto Y; Tokumasu A; Uwatsu K; Kanzaki H; Takata N; Ishikawa H; Ouchi A; Mochizuki T
    Int J Clin Oncol; 2019 Sep; 24(9):1119-1128. PubMed ID: 31079257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
    Kim HS; Kim CK; Park BK; Huh SJ; Kim B
    J Magn Reson Imaging; 2013 Jan; 37(1):187-93. PubMed ID: 23018989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.
    Kuang F; Yan Z; Wang J; Rao Z
    Magn Reson Imaging; 2014 May; 32(4):342-9. PubMed ID: 24512795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
    Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
    Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
    Zhao M; Zhao L; Yang H; Duan Y; Li G
    Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
    Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
    Qin F; Pang H; Ma J; Xu H; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2023 Dec; 169():111181. PubMed ID: 37939604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy.
    Li XS; Fan HX; Fang H; Song YL; Zhou CW
    J Magn Reson Imaging; 2015 Sep; 42(3):681-8. PubMed ID: 25581675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravoxel incoherent motion diffusion-weighted imaging evaluated the response to concurrent chemoradiotherapy in patients with cervical cancer.
    Bian H; Liu F; Chen S; Li G; Song Y; Sun M; Dong H
    Medicine (Baltimore); 2019 Nov; 98(46):e17943. PubMed ID: 31725650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.